The suitability of quality-of-life questionnaires for psoriasis research: A systematic literature review

Archives of Dermatology

Volumn 138, Issue 9, 2002, Pages 1221-1227

  De Korte, John ^a   Mombers, Femke M C ^a   Sprangers, Mirjam A G ^a   Bos, Jan D ^a   Corona, Rosamaria ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL RESEARCH; PRIORITY JOURNAL; PSORIASIS; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; REVIEW;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; CHRONIC DISEASE; DERMATOLOGY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; PSORIASIS; PSYCHOLOGY, SOCIAL; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESEARCH; SEVERITY OF ILLNESS INDEX;

EID: 0036718359     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Assessment of quality-of-life outcomes
2. A critical appraisal of the quality of quality-of-life measurements
3. Measuring health-related quality of life
4. Quality of life measures in health care, I: Applications and issues in assessment
5. Quality of life measures in health care, III: Resource allocation
6. Assessment of values, utilities and preferences in cancer patients
7. Effect of cyclosporin A on quality of life in psoriasis and atopic eczema
8. The effect of severe psoriasis on the quality of life of 369 patients
9. Commercial tanning bed treatment is an effective psoriasis treatment: Results from an uncontrolled clinical trial
10. Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress
11. Feelings of stigmatization in patients with psoriasis
12. Psychological consequences of rejection and stigma feelings in psoriasis patients
13. The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures
14. A psychocutaneous profile of psoriasis patients who are stress-reactors
15. Age and gender differences in the impact of psoriasis on quality of life
16. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment
17. Dermatology in-patient management greatly improves life quality
18. The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort
19. The application of multiple quality-of-life instruments in individual with mild-to-moderate psoriasis
20. Postal questionnaire study of disability in the community associated with psoriasis
21. The physical, psychological and social impact of psoriasis
22. Psoriasis causes as much disability as other major medical diseases
23. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis
24. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis
25. The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis
26. Coping and quality of life in patients with psoriasis
27. A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis
28. Quality of life in adults with chronic illness: A psychometric study
29. The brief symptom inventory: An introductory report
30. Psoriasis: An index of disability
31. Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use
32. Validation of the Sickness Impact Profile and the Psoriasis Disability Index in psoriasis
33. The psoriasis life stress inventory: A preliminary index of psoriasis-related stress
34. Handicap in inflammatory arthritis
35. The Children's Dermatology Life Quality Index (CDLQI): Initial validation and practical use
36. Coping with acne vulgaris
37. Health-related quality of life in psoriasis: A biopsychosocial model and measures
38. Dimensions of stigmatization in patients with psoriasis in a "Questionnaire on Experience With Skin Complaints."
39. Measuring health status: A new tool for clinicians and epidemiologists
40. A quantitative approach to perceived health status: A validation study
41. Validating the SF-36 health survey questionnaire: New outcome measure for primary care
42. Criterion validity and reliability of the SF-36 in a population sample
43. The MOS-36-item short form health survey (SF-36), II: Psychometric and clinical tests of validity in measuring physical and mental health constructs
44. The MOS-36-item short form health survey (SF-36), III: Tests of data quality, scaling assumptions, and reliability across diverse patient groups
45. The MOS-36-item short form health survey (SF-36), I: Conceptual framework and item selection
46. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the medical outcomes study
47. The sickness impact profile: Validation of a health status measure
48. The sickness impact profile: Development and final revision of a health status measure
49. Sickness impact profile: The state of the art of a generic functional status measure
50. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: Clinical validity, reliability and sensitivity to change of the DLQI
51. Dermatology quality of life scales: A measure of the impact of skin diseases
52. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease
53. Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis
54. Effect of cyclosporine A on quality of life in psoriasis and atopic eczema
55. Validation of the sickness impact profile and the psoriasis disability index in psoriasis
56. The development of a short generic version of the Sickness Impact Profile
57. The sickness impact profile: SIP68, a short generic version, first evaluation of the reliability and reproducibility
58. Development and validation of a quality of life instrument for cutaneous diseases
59. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases
60. Skindex, a quality of life measure for patients with skin disease: Reliability, validity, and responsiveness
61. Skindex, a dermatological outcomes measure of the effects of skin disease on patients' quality of life